TIDMACRL

RNS Number : 2390K

Accrol Group Holdings PLC

20 December 2022

20 December 2022

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Accrol Group Holdings plc

("Accrol" or the "Company")

Director Dealing

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, has been notified that Gareth Jenkins, the Chief Executive Officer, for personal reasons, has sold 1,000,000 ordinary shares of GBP0.001 each ("Ordinary Shares") at a price of 28.0 pence per Ordinary share.

Following this disposal, Gareth is interested in 4,422,929(1) Ordinary Shares representing 1.39% of the issued share capital of the Company.

(1) 3,741,346 of these Ordinary Shares are registered in the name of Gareth's wife Susan Jenkins.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
      Details of the person discharging managerial 
  1    responsibilities / person closely associated 
 a)   Name                   Gareth Jenkins 
     ---------------------  ---------------------------- 
 2    Reason for the notification 
     --------------------------------------------------- 
 a)   Position/status        CEO 
     ---------------------  ---------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
     ---------------------  ---------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, 
       auctioneer or auction monitor 
     --------------------------------------------------- 
 a)   Name                   Accrol Group Holdings plc 
     ---------------------  ---------------------------- 
 b)   LEI                    213800MC56M5G69RJ226 
     ---------------------  ---------------------------- 
 4    Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
     --------------------------------------------------- 
 a)   Description            Ordinary shares of GBP0.001 
       of the financial       each 
       instrument, 
       type of instrument 
       Identification 
       code                   ISIN: GB00BZ6VT592 
     ---------------------  ---------------------------- 
 b)   Nature of the          Sale of Ordinary shares 
       transaction 
     ---------------------  ---------------------------- 
 c)   Price(s) and             Price(s)    Volume(s) 
       volume(s)                GBP0.28     1,000,000 
                                           ---------- 
     ---------------------  ---------------------------- 
 d)   Date of the            19 December 2022 
       transaction 
     ---------------------  ---------------------------- 
 e)   Place of the           London Stock Exchange, AIM 
       transaction 
     ---------------------  ---------------------------- 
 
 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
Richard Newman, Chief Financial Officer 
 
Zeus (Nominated Adviser & Broker) 
Dan Bate / Jordan Warburton                  Tel: +44 (0) 161 831 1512 
Dominic King                                 Tel: +44 (0) 203 829 5000 
 
Liberum Capital Limited (Joint Broker)       Tel: +44 (0) 20 3100 2222 
Clayton Bush / Edward Thomas 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 078 
Keeley Clarke                                Tel: +44 (0) 7967 816 525 
                                              accrolpr@belvederepr.com

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at GBP2.1bn at retail sales value.

The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today .

For more information, please visit www.accrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFFFLIFALALIF

(END) Dow Jones Newswires

December 20, 2022 02:00 ET (07:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Accrol Charts.